Risankizumab (anti-IL-23)
A2046
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameRisankizumab (anti-IL-23)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionRisankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohns disease.
- Storage Instruction2°C to 8°C
- UNSPSC12352203